Special Reports

The first episode of schizophrenia is a critical period of illness.

Meeting the needs of the dying and their families requires a deep and clear understanding of competent and compassionate care.

Intensive caring offers a way of addressing suffering designed to better meet the needs of patients and families.

Far less attention is paid by mental health clinicians to aspects of death and dying. This Psychiatric Times Death and Dying Special Report helps fill some of that gap.

What is the best treatment course for prolonged grief disorder?

Cannabis use during adolescence can profoundly impact brain development.

Social media is here to stay, and its use must be a consideration in the treatment of psychiatric conditions, particularly substance use disorder and alcohol use disorder.

Learn more about cannabis use and social media addiction in this month's Special Report!

Whether a patient has a diagnosis of cPTSD, BPD, or some combination of both, treatment should be considered multifaceted and overlapping. Learn more in this Special Report article.

For those who have experienced trauma and suffer a subsequent mental health disorder, ongoing research is identifying psychotherapies, medications, and lifestyle changes that can help.

Additionally, 27% of US adults have reported they have a disability across a spectrum of areas.

Recent research found approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.

Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?

Review tapering challenges and strategies for benzodiazepines in this Special Report article.

Check out the latest results from the phase 3 CONNEX-X study.

In this Special Report, get the latest from the American Psychiatric Association Annual Meeting!

An expert shares 7 principles for clinicians to consider when prescribing multiple medications for a patient.

Clinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric diseases and periodically review all prescribed medications. Learn more here.

What are the risks and benefits of antipsychotic polypharmacy for the treatment of schizophrenia?

Polypharmacy is often overlooked in patients with significant traumatic brain injury. How can you best manage medication in these patients?

What are the connections between what we eat and disorders such as anxiety and depression?

Climate change is a global public health crisis.

The articles in this Psychiatric Times Special Report highlight the relationship of health to the environment.

Here's how embracing a comprehensive, patient-centered approach and staying informed about emerging treatments can help mental health professionals make a difference in the lives of patients with TRD.

Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.

The Psychiatric Times Special Report on Treatment-Resistant Depression includes expert discussions on how clinicians can manage major depressive disorder and treatment-resistant depression in patients who do not achieve wellness right away.

Diagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.

In patients seen in the medical setting, as many as 20% have personality disorders.